• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Digirad completes equity financing

Article

Solid-state digital gamma camera developer Digirad has received a $20 million cash infusion from a venture capital group. The San Diego-based vendor will use the equity financing to scale up manufacturing and build a sales and marketing infrastructure to

Solid-state digital gamma camera developer Digirad has received a $20 million cash infusion from a venture capital group. The San Diego-based vendor will use the equity financing to scale up manufacturing and build a sales and marketing infrastructure to support the launch of Digirad 2020 TC Imager, nuclear medicine's first solid-state digital camera cleared for marketing in the U.S. The venture capital group is led by Vector Fund Management, according to the company.

Digirad received Food and Drug Administration 510(k) clearance for 2020 TC Imager just days before the start of the Society of Nuclear Medicine meeting in San Diego (SCAN 6/11/97). The scanner, formerly known as Notebook Imager, is the company's first commercially available product.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.